Table 5.
Outcome name | Shift workers | Jet lag | Insomnia | Initiation of Sleep/Sleep efficacy | Daytime sleepiness (occurrence of)/Somnolence | Phase shift/hormone changes |
---|---|---|---|---|---|---|
Objective measures | ||||||
Polysomnographic recording (PSG)*; Actigraph*; Saliva samples**; Blood samples**; Electroencephalogram (EEG)*; Accelerometers*; Hours of sleep*; Heart rate/Heart rate variability (HR/HRV)*; Melatonin assays*; Multiple sleep latency test(MSLT)*; Urine samples**; 5- min reaction test* | 7 | 6 | 2 | 9 | 1 | 9 |
Subjective measures | ||||||
Visual Analog Scale (VAS)*; Sleep diaries; Stanford Sleepiness Scale (SSS)*; Profile of Mood States (POMS)*; Karolinska Sleepiness Scale (KSS)*; Daily Sleep Questionnaire (DSQ); Questionnaire; 7 point Likert Drowsiness Scale; Accumulated Time with Sleepiness Scale (ATS)*; Accumulated Time with Sleepiness Scale (ATS)*; Bond-Lader Questionnaire; Columbia Jet Lag Scale*; Daily Subjective Sleep Experiencing Questionnaire (DSSEQ); Leeds Sleep Evaluation Questionnaire*; Linear Sleepiness Rating; Pittsburgh Sleep Quality Index (PSQI)*; Retrospective ratings; Subjective Sleep Quality Questionnaire; Symptom assessments; Symptom questionnaire | 21 | 24 | 8 | 5 | 6 | 3 |
*Validated Measures.
**Objective measures captured to determine melatonin bioavailability but not relevant outcomes of interest to this review.